Please login to the form below

PRAC

This page shows the latest PRAC news and features for those working in and with pharma, biotech and healthcare.

FDA rejects Allergan’s uterine fibroid drug over safety concerns

The findings were backed up by the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC), which concluded that Esmya may have contributed to the development of some cases of serious liver injury.

Latest news

MHRA suspends new prescriptions of fibroid drug Esmya

In December, the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) started a review of the treatment for abnormal bleeding in women with uterine fibroids after four cases of serious liver injury -
Patient reporting rises after EU pharmacovigilance reforms

The 2012 reforms gave new powers to the EMA and created a Pharmacovigilance Risk Assessment Committee (PRAC) that helped to coordinate the activities of both the centralised agency and national regulatory ... Patient and healthcare professional
Gilead's Zydelig passes EMA safety review

The PRAC has now updated recommendations for use to manage the potential problems. ... If patients suffer from a generalised infection, they should not begin treatment with Zydelig, PRAC says.
EMA review clears GSK and Sanofi Pasteur MSD HPV vaccines

effects. The regulator's Pharmacovigilance Risk Assessment Committee (PRAC) ruled out a connection between Cervarix and Gardasil and complex regional pain syndrome (CRPS) or postural orthostatic tachycardia syndrome (POTS). ... However, the EMA's
EMA launches review of cervical cancer vaccine safety

The EMA said its pharmacovigilance risk assessment committee (PRAC) will now examine the available data on CRPS and PoTS to see whether there may be a causal link with HPV vaccination

More from news
Approximately 5 fully matching, plus 26 partially matching documents found.

Latest Intelligence

Changes to pharmacovigilance legislation in Europe

If the same safety concerns apply to more than one medicinal product, the competent authority may, following consultation with the Pharmacovigilance Risk Assessment Advisory Committee (PRAC), encourage the performance of a ... Among others activities,

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

Dr June Raine continues as chair of EMA's pharmacovigilance committee

The EMA has extended the tenure of Dr June Raine as chair for its Pharmacovigilance Risk Assessment Committee (PRAC). ... Under her leadership Dr Raine said the PRAC would have three key priorities:. •
EMA’s Pharmacovigilance Risk Assessment Committee gains new members

The European Medicines Agency's (EMA) newest committee - the Pharmacovigilance Risk Assessment Committee (PRAC) - has added two new members. ... Its new members Babylon and van der Zeijden will participate in the PRAC from April 2013.
MHRA's Dr June Raine to chair new EMA pharmacovigilance committee

MHRA's Dr June Raine to chair new EMA pharmacovigilance committee. Pharmacovigilance Risk Assessment Committee (PRAC) will lead implementation of reforms. ... The PRAC will lead implementation of the wide-ranging pharmacovigilance reforms the EMA brought

More from appointments
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Market Access Consultant - Greater Manchester: Negotiable

Senior Writer, Healthcare Advertising, London: Excellent package

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Medical Writer - Creative and Scientific Projects: DOE

Senior Medical Writer, MedComms Agency: Salary TBC

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Account Director, Healthcare Advertising Agency: Salary TBC

Medical Writers Required - Hertfordshire: Competitive

Account Manager- 4 days per week or full-time: Salary TBC

Systematic Review Lead- London: Negotiable

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Sudler London - Account Director: Competitive

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Healthcare PR Director: £100, 000 – £120, 000 benefits

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Senior Medical Writer: Salary is DOE

Senior Training Manager - Surrey: Competitive Salary &Bonus

Senior Account Manager – Healthcare Advertising: Salary TBC

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Account Manager: Negotiable

Healthcare PR Senior Account Manager: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Adelphi Research UK

Adelphi Research UK is a healthcare insight partner. We uniquely blend robust market research with a consultancy approach, to guide...

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....